Bio-Techne
TECH
240 hedge funds and large institutions have $2.94B invested in Bio-Techne in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 94 increasing their positions, 86 reducing their positions, and 24 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 86
2% less funds holding
Funds holding: 245 → 240 (-5)
8% less capital invested
Capital invested by funds: $3.19B → $2.94B (-$247M)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$108M |
| 2 |
Select Equity Group
New York
|
+$53.1M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$24.8M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$18.5M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$18.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$46.5M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
-$33.5M |
| 3 |
Morgan Stanley
New York
|
-$33.2M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$20.1M |
| 5 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
-$18.8M |
TECH Hedge Fund Activity: Q1 2014 in Review
240 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2014, worth a combined $2.94B — down 7.7% from $3.19B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of TECH and 21 opened new positions — a net loss of 3 holders — while 86 trimmed existing stakes and 94 added.
The largest buyer was William Blair & Company, adding an estimated $108M. The largest seller was Kayne Anderson Rudnick Investment Management, cutting an estimated $46.5M.
- 240 institutional investors held Bio-Techne (TECH) as of Q1 2014, down from 245 in Q4 2013.
- Funds reported $2.94B of Bio-Techne stock for Q1 2014, down 7.7% quarter-over-quarter.
- 21 funds opened new Bio-Techne positions in Q1 2014 and 24 closed out, a net change of -3 holders.
- The largest Bio-Techne buyer in Q1 2014 was William Blair & Company, an estimated $108M added.
- The largest Bio-Techne seller in Q1 2014 was Kayne Anderson Rudnick Investment Management, an estimated $46.5M sold.
Based on aggregated 13F filings for Q1 2014.